Intra-Cellular pushes back on stereotypes in first DTC campaign for caplyta

everhopeful · September 15, 2020, 5:35pm

Wave · September 15, 2020, 5:47pm

I thought that the TV commercial was positive.

Topic		Replies	Views
Intra-Cellular Therapies Initiates Promotional Activities for CAPLYTA™ (lumateperone) for the Treatment of Schizophrenia in Adults News	0	301	April 2, 2020
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia Medications	0	40	November 5, 2024
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia News	6	522	March 23, 2020
Intra-Cellular's Caplyta scores again in major depressive disorder as blockbuster expansion comes within reach Medications	11	199	June 20, 2024
Intra-Cellular's Caplyta Is Likely A Blockbuster For Bipolar Depression Barring Generic Entry Medications	5	364	March 10, 2023